Curapath Receives Accreditation as a GMP Investigational Drug Product Manufacturer from the Spanish Agency for Medicine and Health Products

VALENCIA, Spain & BOSTON–(BUSINESS WIRE)–Curapath, a leader in the design, development, and custom manufacturing of polyamino-acid- and lipid nanoparticle (LNP) delivery systems for therapeutics and vaccines, today announced the company has received accreditation as a GMP investigational drug product manufacturer from the Spanish Agency for Medicine and Health Products (AEMPS)….